| Bid Price | 1886.00p | High Price | 1895.00p |
|---|
| Ask Price | 1887.00p | Low Price | 1867.00p |
|---|
| Open Price | 1888.00p | Spread | 0.05% |
|---|
| Prev Close | 1891.00p | Volume | 330,178 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 17, 2025 | 1888.00 | 1895.00 | 1867.00 | 1885.00 | 330,178 |
| Apr 16, 2025 | 1899.00 | 1908.00 | 1881.00 | 1891.00 | 296,579 |
| Apr 15, 2025 | 1874.00 | 1914.00 | 1873.00 | 1907.00 | 479,401 |
| Apr 14, 2025 | 1860.00 | 1876.00 | 1832.00 | 1869.00 | 313,745 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 220.43 m | Prev Close | 1891.00p |
|---|
| PE Ratio | 15.492117 | Market Cap | £4.16 bn |
|---|
| Div Yield | 3.24 | Div per Share | $0.32 |
|---|
| EPS | $0.60 | Div Cover | 1.8750 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.042827 | DPS Growth (%) | 0.2775 |
|---|
| Current Ratio | 1.144085 | Quick Ratio | 0.565217 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/03/25 | TIN | Mazen Darwazah | CH | 14,844 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Said Darwazah | CEO | 18,420 @ £0.00 | £0.00 |
| 04/03/25 | EXR | Riad Mishlawi | CEO | 19,890 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Riad Mishlawi | CEO | 18,691 @ £0.00 | £0.00 |
| 24/09/24 | DRIP | Riad Mishlawi | CEO | 509 @ £19.03 | £9,686.00 |
| 09/05/24 | DRIP | Riad Mishlawi | CEO | 736 @ £19.79 | £14,565.00 |
| 13/03/24 | TIN | Mazen Darwazah | CH | 26,812 @ £0.00 | £0.00 |
| 13/03/24 | TIN | Mazen Darwazah | CH | 13,903 @ £0.00 | £0.00 |
| 13/03/24 | TIN | Said Darwazah | CEO | 34,652 @ £0.00 | £0.00 |
| 13/03/24 | TIN | Said Darwazah | CEO | 19,830 @ £0.00 | £0.00 |
Hikma Pharmaceuticals PLC News
